Nov 22, 2022 01:01AM
Nov 22, 2022 01:01AM
Nov 3, 2022 04:01PM
Aug 29, 2022 05:14AM
Aug 23, 2022 09:13AM
Aug 23, 2022 06:07AM
Aug 22, 2022 09:20PM Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
Aug 22, 2022 09:18PM
Feb 24, 2022 04:01PM
Feb 24, 2022 06:30AM
Feb 24, 2022 06:30AM
Dec 22, 2021 04:01PM
Dec 16, 2021 06:31AM
Dec 16, 2021 06:30AM Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
Dec 7, 2021 05:30AM
Dec 7, 2021 02:00AM
Nov 4, 2021 04:01PM
Oct 12, 2021 06:30AM
Oct 12, 2021 06:30AM
Sep 21, 2021 06:31AM
Sep 21, 2021 06:30AM Aerie Pharmaceuticals, Inc. Announces the Appointment of Interim Executive Chair and Departure of Chairman and CEO
Sep 20, 2021 06:30AM
Sep 15, 2021 04:03PM
Sep 15, 2021 04:01PM
Sep 13, 2021 06:30AM
Sep 7, 2021 06:30AM
Aug 4, 2021 04:01PM
Jul 15, 2021 06:30AM Aerie Pharmaceuticals Announces Appointment of Leon J. Atencia, Director of Regulatory Affairs
Jun 21, 2021 07:00AM
Jun 17, 2021 06:30AM
May 5, 2021 04:01PM
Apr 29, 2021 06:30AM
Apr 28, 2021 06:30AM
Apr 19, 2021 06:32AM
Apr 19, 2021 06:30AM Aerie Pharmaceuticals Receives Marketing Authorisation of Roclanda® 50 micrograms/ml + 200 micrograms/ml Eye Drops, Solution (latanoprost + netarsudil) in Great Britain
Mar 30, 2021 08:10AM
Mar 30, 2021 08:05AM
Feb 25, 2021 04:01PM
Jan 11, 2021 06:40AM
Jan 11, 2021 06:30AM
Nov 13, 2020 06:50AM
Nov 13, 2020 06:50AM Aerie Pharmaceuticals Receives Positive CHMP Opinion for Roclanda® in the European Union
Nov 5, 2020 04:01PM
Oct 29, 2020 06:30AM
Oct 28, 2020 03:00AM
Sep 29, 2020 06:31AM
Sep 29, 2020 06:30AM
Sep 24, 2020 06:32AM
Sep 24, 2020 06:30AM Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial in Europe
Sep 15, 2020 06:45AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All